SOUTHWELL MEDICAL CENTRE
THE ROPEWALK, SOUTHWELL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 14 | 64.3% | |
| HF 4 | 2011 | 10 | 16 | 62.5% | |
| HF 4 | 2012 | 10 | 10 | 100.0% | |
| HF 4 | 2013 | 9 | 12 | 75.0% | |
| HF004 | 2014 | 1 | 1 | 100.0% | |
| HF004 | 2015 | 2 | 2 | 100.0% | |
| HF004 | 2016 | 1 | 1 | 100.0% | |
| HF004 | 2017 | 28 | 34 | 82.4% | |
| HF004 | 2018 | 31 | 34 | 91.2% | |
| HF004 | 2019 | 36 | 40 | 90.0% | |
| HF004 | 2020 | 33 | 37 | 89.2% | |
| HF006 | 2021 | 39 | 41 | 95.1% | |
| HF006 | 2022 | 36 | 38 | 94.7% | |
| HF006 | 2023 | 47 | 52 | 90.4% |
